Viewing Study NCT01219933


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-31 @ 1:59 AM
Study NCT ID: NCT01219933
Status: COMPLETED
Last Update Posted: 2015-01-19
First Post: 2010-10-11
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Glucocorticoid Use to Evaluate Systematic Methylprednisolone Reduction in Patients With Rheumatoid Arthritis on Background RoActemra/Actemra (Tocilizumab) (ACT-ALONE)
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-01
Start Date Type: None
Primary Completion Date: 2013-03
Primary Completion Date Type: ACTUAL
Completion Date: 2013-03
Completion Date Type: ACTUAL
First Submit Date: 2010-10-11
First Submit QC Date: None
Study First Post Date: 2010-10-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2014-08-26
Results First Submit QC Date: None
Results First Post Date: 2015-01-19
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-01-15
Last Update Post Date: 2015-01-19
Last Update Post Date Type: ESTIMATED